Related by context. Frequent words. (Click for all words.) 62 belimumab 61 plus methotrexate 59 adalimumab 58 sustained virologic response 58 decitabine 57 inflammatory lesions 56 mg kg dose 55 annualized relapse 55 certolizumab pegol 55 STELARA 55 PROMACTA 54 mg BID 54 anakinra 54 cytogenetic response 54 tumor regression 53 clinically meaningful 53 etanercept 53 VIDAZA 53 peginterferon alfa 2a 52 statistically significant reduction 52 adefovir 52 azacitidine 52 placebo p 52 statistically significant improvement 52 abatacept 52 secondary efficacy endpoints 52 tocilizumab 52 bosentan 52 Secondary endpoints include 52 Secondary endpoints 52 log# 52 pramipexole 51 methotrexate MTX 51 xenograft models 51 Secondary endpoints included 51 placebo p = 50 pharmacodynamic 50 ACR# [002] 50 administered subcutaneously 50 infliximab 50 peginterferon alfa 2b 50 Trastuzumab 50 Combination therapy 50 active comparator 50 chronic lymphocytic leukemia CLL 50 virologic failure 50 imetelstat 50 nilotinib 50 plus ribavirin 50 ACTEMRA 49 Cimzia ® 49 tumor shrinkage 49 HbA1c levels 49 mg QD 49 lacosamide 49 A1C levels 49 myelosuppression 49 fluticasone 49 rituximab 49 darbepoetin alfa 49 fasting plasma glucose 49 diabetic neuropathic pain 49 TORISEL 49 discontinuations due 49 secondary endpoints 49 Infliximab 49 interferon alfa 49 fondaparinux 49 tiotropium 49 RECIST criteria 49 natalizumab 49 ADAS cog 48 FOLFIRI 48 P = .# 48 SEROQUEL 48 seliciclib 48 subcutaneous injections 48 bortezomib 48 DAS# [002] 48 DMARDs 48 mediated immunity 48 serum phosphorus 48 nab paclitaxel 48 hypomagnesemia 48 fasting insulin 48 mitoxantrone 48 IPSS 48 tumor lysis syndrome 48 rotigotine 48 exacerbations 48 DMARD 47 fluorouracil 47 pazopanib 47 undetectable viral load 47 peginterferon 47 dasatinib 47 mg dose 47 pegylated interferon 47 SEROQUEL XR 47 Torisel 47 SCH #